【総説】
・Ogawa, T., Ono, S., Ichikawa, T., Arimitsu, S., Onoda, K., Tokunaga, K., Sugiu, K., Tomizawa, K., Matsui, H., and Date, I. Protein transduction method for cerebrovascular disorders. Acta Med. Okayama63, 1-7, 2009.
・富澤一仁．Cdk5の非神経細胞における機能：インスリン分泌の制御。蛋白質核酸 酵素54: 808-812, 2009.
・富澤一仁．蛋白質導入法によるiPS細胞作製技術開発(2)。再生医療8: 52-56, 2009.
【原著論文】
・Takayama, K., Nakase, I., Michiue, H., Takeuchi, T., Tomizawa, K., Matsui, H., and Futaki, S.Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).J Control Release138: 128-133, 2009.
・Nishiyama, Y., Yokoyama, T., Tomizawa, K., Okamura, K., Yamamoto, Y., Matsui, H., Oguma, K., Nagai, A., and Kumon, H.Effects of purified newly developed botulinum neurotoxin type A in rat prostate.Urology74: 436-439, 2009
・Feng, B., Tomizawa, K., Michiue, H., Miyatake, S., Han, X.-H., Fujimura, A., Seno, M., Kirihata, M., and Matsui, H. Delivery of sodium borocaptate to glioma cells using immunoliposome conjugated with anti-EGFR antibodies by ZZ-His. Biomaterials 30: 1746-1755, 2009.
